• Sarepta’s DMD drug Elevidys to carry liver failure warning The Pharma Letter Mon, 17 Nov 2025 14:18:29 GMT
• FDA Imposes Boxed Warning, Narrows Patient Pool for Sarepta’s Duchenne Gene Therapy Elevidys BioSpace Mon, 17 Nov 2025 13:14:38 GMT
• FDA hits Sarepta with liver warning labelling for its DMD drug Elevidys European Pharmaceutical Review Mon, 17 Nov 2025 13:04:20 GMT
• FDA approves Sarepta’s updated Elevidys label for DMD Pharmaceutical Technology Mon, 17 Nov 2025 10:39:06 GMT
• Sarepta Stock Slides Premarket After New FDA Warning Shrinks Market For Its $3.2M DMD Gene Therapy MSN Mon, 17 Nov 2025 10:04:24 GMT
• Why Sarepta Therapeutics (SRPT) Is Down After FDA Adds Boxed Warning and Use Restrictions for ELEVIDYS simplywall.st Mon, 17 Nov 2025 08:25:22 GMT
• smart tools for monitoring sarepta therapeutics inc.’s price action - 2025 fundamental recap & risk controlled stock alerts newser.com Sun, 16 Nov 2025 07:24:28 GMT
• Cautious Hold Rating on Sarepta Therapeutics Amid Elevidys Label Updates and Safety Concerns TipRanks Sat, 15 Nov 2025 17:29:33 GMT
• Sell Rating for Sarepta Therapeutics Amid Label Changes and Market Challenges TipRanks Sat, 15 Nov 2025 17:29:30 GMT
• Is Sarepta Therapeutics a Bargain After Its 82% Drop Over the Last Year? Yahoo Finance Sat, 15 Nov 2025 16:09:29 GMT
• will sarepta therapeutics inc. (ab3a) stock test record highs in 2025 newser.com Sat, 15 Nov 2025 15:30:36 GMT
• Sarepta Duchenne gene therapy gets strongest FDA label after patient deaths The Business Journals Sat, 15 Nov 2025 11:59:00 GMT
• Is Sarepta Therapeutics a Bargain After Its Recent 85% Stock Slide in 2025? simplywall.st Sat, 15 Nov 2025 03:41:30 GMT
• Sarepta’s Elevidys Limited To Ambulatory DMD Patients; Study In Non-Ambulatory Patients Planned Citeline News & Insights Sat, 15 Nov 2025 02:15:28 GMT
• STATE STREET CORP's Strategic Acquisition of Sarepta Therapeutics Inc Shares GuruFocus Sat, 15 Nov 2025 01:07:10 GMT
• sarepta’s elevidys limited to ambulatory dmd patients Citeline News & Insights Fri, 14 Nov 2025 23:31:12 GMT
• Sarepta Shares Jump After FDA Approves Updated Elevidys Label Benzinga Fri, 14 Nov 2025 22:48:37 GMT
• US FDA adds strongest warning to Sarepta’s Elevidys after fatal liver injuries 104.1 WIKY Fri, 14 Nov 2025 22:44:12 GMT
• us fda adds strongest warning to sarepta's elevidys after fatal liver injuries Reuters Fri, 14 Nov 2025 22:31:19 GMT
• Sarepta Therapeutics (SRPT) Faces Setback with FDA Warning on El GuruFocus Fri, 14 Nov 2025 22:01:45 GMT
• Sarepta gene therapy Elevidys gets FDA Boxed Warning following two patient deaths Seeking Alpha Fri, 14 Nov 2025 21:24:02 GMT
• sarepta gains fda approval for updated safety guidance on duchenne gene therapy MarketScreener Fri, 14 Nov 2025 21:04:19 GMT
• sarepta (srpt) updates elevidys prescribing information with new safety measures GuruFocus Fri, 14 Nov 2025 20:40:27 GMT
• FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths The Press Democrat Fri, 14 Nov 2025 20:39:20 GMT
• F.D.A. Sharply Limits Use of Drug Linked to Two Teen Deaths The New York Times Fri, 14 Nov 2025 20:23:02 GMT
• fda restricts sarepta's gene therapy elevidys after duchenne patient deaths Fierce Pharma Fri, 14 Nov 2025 20:20:28 GMT
• Sarepta’s DMD gene therapy receives updated label with safety warnings Investing.com Fri, 14 Nov 2025 20:13:52 GMT
• Sarepta Announces FDA’s Approval of Updated ELEVIDYS Prescribing Information Sarepta Therapeutics Fri, 14 Nov 2025 19:54:00 GMT
• fda revises labeling for sarepta's (srpt) elevidys following liv GuruFocus Fri, 14 Nov 2025 19:40:17 GMT
• Sarepta’s Elevidys to Remain on Market With New FDA Warning Bloomberg.com Fri, 14 Nov 2025 19:30:21 GMT
• what drives sarepta therapeutics inc stock price - rsi overbought/oversold & breakthrough profit margins earlytimes.in Fri, 14 Nov 2025 19:18:53 GMT
• sarepta stock rises after fda adds safety warning but maintains approval Investing.com Fri, 14 Nov 2025 19:13:12 GMT
• us fda adds strongest warning to sarepta gene therapy after fatal liver injuries Yahoo Fri, 14 Nov 2025 19:08:17 GMT
• what technical models suggest about sarepta therapeutics inc.’s comeback - portfolio profit report & stock market timing technique... newser.com Fri, 14 Nov 2025 16:48:55 GMT
• (srpt) volatility zones as tactical triggers news.stocktradersdaily.com Fri, 14 Nov 2025 15:38:03 GMT
• Sarepta stock ticks up as FDA finalises tighter Elevidys label FirstWord Pharma Fri, 14 Nov 2025 15:14:23 GMT
• how sarepta therapeutics inc. stock benefits from global expansion - 2025 price action summary & risk adjusted buy/sell alerts newser.com Thu, 13 Nov 2025 19:56:04 GMT
• sarepta therapeutics inc. stock trend forecast - market volume summary & expert curated trade setups newser.com Thu, 13 Nov 2025 16:40:39 GMT
• A Look at Sarepta Therapeutics (SRPT) Valuation Following Mixed ESSENCE Trial Results and Earnings Shift simplywall.st Thu, 13 Nov 2025 15:42:11 GMT
• what technical models suggest about sarepta therapeutics inc.’s comeback - gap up & high accuracy investment signals newser.com Thu, 13 Nov 2025 15:09:59 GMT
• sarepta therapeutics inc. stock trend forecast - july 2025 weekly recap & reliable volume spike trade alerts newser.com Thu, 13 Nov 2025 13:09:14 GMT
• drugs are winning approval even when trials fail — but should they? PharmaVoice Wed, 12 Nov 2025 13:37:42 GMT
• relative strength of sarepta therapeutics inc. in sector analysis - july 2025 movers & daily oversold bounce ideas newser.com Wed, 12 Nov 2025 11:55:55 GMT
• fda names longtime oncology chief richard pazdur as new cder director Fierce Pharma Tue, 11 Nov 2025 22:18:12 GMT
• multi asset correlation models including sarepta therapeutics inc. - weekly stock recap & real-time market sentiment alerts newser.com Tue, 11 Nov 2025 19:10:54 GMT
• what technical models suggest about sarepta therapeutics inc.’s comeback - weekly investment report & free growth oriented trading... newser.com Tue, 11 Nov 2025 02:13:39 GMT
• catalent cuts 77 more jobs in maryland as gene therapy resizing rolls on Fierce Pharma Mon, 10 Nov 2025 21:18:47 GMT
• will breakout in sarepta therapeutics inc. lead to full recovery - 2025 price targets & expert curated trade setup alerts newser.com Mon, 10 Nov 2025 12:18:09 GMT
• should investors view sarepta (srpt) differently after essence study details and q3 results? simplywall.st Mon, 10 Nov 2025 06:35:17 GMT
• what technical models suggest about sarepta therapeutics inc.’s comeback newser.com Sun, 09 Nov 2025 12:10:32 GMT
• relative strength of sarepta therapeutics inc. in sector analysis - short setup & safe entry momentum stock tips newser.com Sun, 09 Nov 2025 10:02:31 GMT
• how sarepta therapeutics inc. stock benefits from global expansion - 2025 macro impact & weekly chart analysis and guides newser.com Sun, 09 Nov 2025 10:00:08 GMT
• dmd drugs show promise despite trial’s missing main goal: sarepta Muscular Dystrophy News Thu, 06 Nov 2025 18:42:23 GMT
• is sarepta therapeutics inc. trending in predictive chart models - 2025 price action summary & safe entry zone tips newser.com Thu, 06 Nov 2025 12:37:19 GMT
• analysts offer insights on healthcare companies: avadel pharmaceuticals (avdl) and sarepta therapeutics (srpt) The Globe and Mail Thu, 06 Nov 2025 10:48:48 GMT
• is sarepta therapeutics inc. stock ready for a breakout - market growth summary & ai driven stock price forecasts newser.com Thu, 06 Nov 2025 09:33:59 GMT
• what market sentiment indicators show for sarepta therapeutics inc. (ab3a) stock - trade signal summary & weekly high conviction t... newser.com Thu, 06 Nov 2025 06:58:27 GMT
• can sarepta therapeutics inc. (ab3a) stock attract analyst upgrades - 2025 volume leaders & fast momentum stock entry tips fcp.pa.gov.br Thu, 06 Nov 2025 06:51:16 GMT
• when is the best time to exit sarepta therapeutics inc. - july 2025 closing moves & high accuracy swing entry alerts newser.com Thu, 06 Nov 2025 05:13:52 GMT
• how sarepta therapeutics inc. (ab3a) stock reacts to fed tightening - short setup & entry point confirmation signals fcp.pa.gov.br Thu, 06 Nov 2025 03:57:22 GMT
• will sarepta therapeutics inc. (ab3a) stock benefit from fed rate cuts - 2025 pullback review & expert curated trade ideas newser.com Thu, 06 Nov 2025 01:04:45 GMT
• Barclays Maintains Sarepta Therapeutics (SRPT) Equal-Weight Recommendation Nasdaq Thu, 06 Nov 2025 00:07:00 GMT
• Guggenheim Maintains Sarepta Therapeutics (SRPT) Buy Recommendation Nasdaq Thu, 06 Nov 2025 00:04:00 GMT
• is sarepta therapeutics inc. stock a good choice for value investors - 2025 trading recap & daily profit maximizing tips newser.com Wed, 05 Nov 2025 23:57:32 GMT
• is sarepta therapeutics inc. (ab3a) stock testing key support - quarterly investment review & weekly consistent profit watchlists fcp.pa.gov.br Wed, 05 Nov 2025 22:41:22 GMT
• bank of america securities keeps their sell rating on sarepta therapeutics (srpt) The Globe and Mail Wed, 05 Nov 2025 22:04:22 GMT
• sarepta therapeutics shares rise after mizuho upgrade MarketScreener Wed, 05 Nov 2025 19:57:18 GMT
• Sarepta Therapeutics (SRPT) Upgraded to Outperform by Mizuho GuruFocus Wed, 05 Nov 2025 19:18:39 GMT
• traders purchase high volume of sarepta therapeutics call options (nasdaq:srpt) MarketBeat Wed, 05 Nov 2025 18:59:25 GMT
• sarepta therapeutics (srpt) sees lowered price target by barclays | srpt stock news GuruFocus Wed, 05 Nov 2025 18:44:35 GMT
• sarepta stock’s (srpt) painful plunge! is there any hope left for investors after dmd trial miss? MSN Wed, 05 Nov 2025 18:36:36 GMT
• sarepta therapeutics (srpt): wells fargo lowers price target to $45 | srpt stock news GuruFocus Wed, 05 Nov 2025 16:15:39 GMT
• sarepta therapeutics (nasdaq:srpt) shares gap down after earnings miss MarketBeat Wed, 05 Nov 2025 15:58:10 GMT
• sarepta therapeutics (srpt) maintains "buy" rating as price targ GuruFocus Wed, 05 Nov 2025 15:47:36 GMT
• analyst ratings send ripples through markets: sarepta's resilience vs. pinterest's plunge Markets Financial Content Wed, 05 Nov 2025 15:23:00 GMT
• mizuho upgrades sarepta on confidence in elevidys uptake Investing.com Wed, 05 Nov 2025 14:53:43 GMT
• pfizer and novo battle over metsera, tidmarsh fights fda exit, uniqure and sarepta face setbacks BioSpace Wed, 05 Nov 2025 14:11:17 GMT
• a quick look at today's ratings for sarepta therapeutics(srpt.us), with a forecast between $5 to $26 富途牛牛 Wed, 05 Nov 2025 13:00:01 GMT
• sarepta therapeutics (srpt) upgraded by mizuho with increased pr GuruFocus Wed, 05 Nov 2025 11:35:51 GMT
• hussman strategic advisors inc. has $1.08 million stock position in sarepta therapeutics, inc. $srpt MarketBeat Wed, 05 Nov 2025 10:08:04 GMT
• mizuho upgrades sarepta therapeutics (srpt) to outperform StreetInsider Wed, 05 Nov 2025 09:35:14 GMT
• sarepta stock dives 34% after earnings report. why shares are crashing. Barron's Wed, 05 Nov 2025 08:31:00 GMT
• sarepta therapeutics confirmatory trial for dmd treatments vyondys 53 and amondys 45 fails to meet primary endpoints geneonline.com Wed, 05 Nov 2025 08:05:35 GMT
• How the Story Around Sarepta Therapeutics Is Shifting Amid New Analyst Reactions and Clinical Updates Yahoo Finance Wed, 05 Nov 2025 08:00:00 GMT
• Mizuho upgrades Sarepta Therapeutics stock to Outperform on Elevidys adoption Investing.com Wed, 05 Nov 2025 08:00:00 GMT
• Does Sarepta Therapeutics' 33% Drop Signal a Possible Market Mispricing? simplywall.st Wed, 05 Nov 2025 08:00:00 GMT
• This Sarepta Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday Benzinga Wed, 05 Nov 2025 08:00:00 GMT
• Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q3 2025 Earnings Call Transcript Insider Monkey Wed, 05 Nov 2025 08:00:00 GMT
• fda faces scrutiny over sarepta drug approval amid concerns of insufficient clinical trial data geneonline.com Wed, 05 Nov 2025 03:57:17 GMT
• sarepta therapeutics’ earnings call: revenue resilience amid challenges TipRanks Wed, 05 Nov 2025 00:14:25 GMT
• baird maintains sarepta therapeutics (srpt) neutral recommendation Nasdaq Wed, 05 Nov 2025 00:06:00 GMT
• sarepta therapeutics shares plummet as key dmd treatments miss primary endpoint in late-stage trial Markets Financial Content Tue, 04 Nov 2025 22:44:00 GMT
• mixed financial signals and future revenue concerns lead to hold rating for sarepta therapeutics TipRanks Tue, 04 Nov 2025 22:40:52 GMT
• sarepta therapeutics (nasdaq:srpt) releases quarterly earnings results, misses expectations by $0.15 eps MarketBeat Tue, 04 Nov 2025 21:51:31 GMT
• palantir, uber, sarepta, tesla, norwegian cruise line, hertz, amd, and more movers Barron's Tue, 04 Nov 2025 21:51:00 GMT
• these stocks moved the most today: palantir, uber, sarepta, tesla, norwegian cruise line, hertz, amd, and more Barron's Tue, 04 Nov 2025 21:51:00 GMT
• sarepta expects tighter elevidys label as amondys/vyondys study sputters Citeline News & Insights Tue, 04 Nov 2025 21:36:44 GMT
• sarepta therapeutics faces criticism following november 2025 blog post on company practices geneonline.com Tue, 04 Nov 2025 21:17:27 GMT
• sarepta plunges on study failures, gene therapy outlook Investor's Business Daily Tue, 04 Nov 2025 21:14:00 GMT
• despite phase 3 failure, sarepta still sees path for muscle disease drugs to secure full fda approval MedCity News Tue, 04 Nov 2025 21:04:38 GMT
• sarepta remains optimistic despite disappointing clinical trial results BioXconomy Tue, 04 Nov 2025 20:14:24 GMT
• sarepta stock tumbles 40%. why the biotech’s shares are sinking. MSN Tue, 04 Nov 2025 19:32:45 GMT
• srpt q3 earnings miss estimates, stock dips on dmd study failure Yahoo Finance Tue, 04 Nov 2025 18:46:00 GMT
• sarepta (srpt) faces stock plunge amid clinical trial setbacks GuruFocus Tue, 04 Nov 2025 17:19:25 GMT
• sarepta stock plummets as confirmatory duchenne trial fails The Business Journals Tue, 04 Nov 2025 17:18:00 GMT
• sarepta stock dumps: pharma bro martin shkreli still likes it Benzinga Tue, 04 Nov 2025 17:11:10 GMT
• sarepta therapeutics stock tumbles after trial data Schaeffer's Investment Research Tue, 04 Nov 2025 16:11:56 GMT
• these stocks are moving the most today: palantir, uber, sarepta, tesla, norwegian cruise line, hertz, amd, and more Barron's Tue, 04 Nov 2025 16:09:00 GMT
• sarepta therapeutics shares plunge after disappointing trial data Invezz Tue, 04 Nov 2025 15:22:30 GMT
• sarepta stock dives 35% after earnings report. why shares are crashing. Barron's Tue, 04 Nov 2025 14:58:00 GMT
• sarepta therapeutics (srpt) stock: clinical failure triggers massive selloff parameter.io Tue, 04 Nov 2025 14:48:47 GMT
• sarepta duchenne drugs come up short in confirmatory test BioPharma Dive Tue, 04 Nov 2025 14:09:20 GMT
• fda duchenne failure hits sarepta amid 3q25 earnings beat (nasdaq:srpt) Seeking Alpha Tue, 04 Nov 2025 13:48:09 GMT
• sarepta’s dmd exon-skippers fail confirmatory study, stock craters BioSpace Tue, 04 Nov 2025 13:40:49 GMT
• needham maintains sarepta therapeutics(srpt.us) with sell rating 富途牛牛 Tue, 04 Nov 2025 13:13:21 GMT
• sarepta says older muscle disease drugs failed confirmatory trial Bloomberg.com Tue, 04 Nov 2025 13:08:03 GMT
• sarepta earnings beat expectations. why the stock is down 40%. Barron's Tue, 04 Nov 2025 13:05:00 GMT
• sarepta slumps after approved muscle disorder drugs fail confirmatory trial TradingView Tue, 04 Nov 2025 12:47:23 GMT
• palantir, sarepta, tesla, uber, pfizer, norwegian cruise line, amazon, amd, and more movers Barron's Tue, 04 Nov 2025 12:45:00 GMT
• confirmatory trial results return sarepta to the doldrums The Pharma Letter Tue, 04 Nov 2025 12:42:20 GMT
• sell rating for sarepta therapeutics amid essence study disappointment and reimbursement concerns TipRanks Tue, 04 Nov 2025 12:41:24 GMT
• sarepta slumps as trial failure deepens woes for drugmaker Yahoo! Finance Canada Tue, 04 Nov 2025 12:22:48 GMT
• two of sarepta’s dmd drugs fail to meet primary endpoint in confirmatory trial Clinical Trials Arena Tue, 04 Nov 2025 11:36:28 GMT
• setback in gene therapy deepens drug pipeline challenges, sarepta shares plunge 40% pre-market. 富途牛牛 Tue, 04 Nov 2025 11:36:00 GMT
• after-hours movers: palantir, hims & hers health, sarepta therapeutics, sanmina Investing.com Tue, 04 Nov 2025 11:04:03 GMT
• sarepta therapeutics (srpt) pt lowered to $15 at baird StreetInsider Tue, 04 Nov 2025 10:15:03 GMT
• sarepta therapeutics (srpt) stock crashes as nine-year trial ends in disappointment CoinCentral Tue, 04 Nov 2025 09:42:04 GMT
• sarepta slumps as gene therapy setback adds to drug pipeline woes Yahoo Finance Tue, 04 Nov 2025 09:29:03 GMT
• pinnacle associates ltd. has $997,000 holdings in sarepta therapeutics, inc. $srpt MarketBeat Tue, 04 Nov 2025 09:16:23 GMT
• stocks to watch tuesday: palantir, sarepta, tesla The Wall Street Journal Tue, 04 Nov 2025 09:13:00 GMT
• sarepta therapeutics swings to q3 adjusted loss, revenue falls; shares down pre-bell MarketScreener Tue, 04 Nov 2025 08:28:12 GMT
• Sarepta Therapeutics’ dismal quarter marred by drug failures and a long list of excuses statnews.com Tue, 04 Nov 2025 08:00:00 GMT
• Sarepta shares tumble on trial failure, weak Elevidys outlook Reuters Tue, 04 Nov 2025 08:00:00 GMT
• Sarepta pushes for full approval of Duchenne drugs despite missed confirmatory trial goal Fierce Pharma Tue, 04 Nov 2025 08:00:00 GMT
• Sarepta Therapeutics (SRPT): Assessing Valuation Following a Recent Rebound Yahoo Finance Tue, 04 Nov 2025 08:00:00 GMT
• Sarepta Therapeutics (SRPT): Losses Narrowed 27.2% Annually, Profitability Targeted Despite -13.9% Revenue Outlook Yahoo Finance Tue, 04 Nov 2025 08:00:00 GMT
• Sarepta Therapeutics (SRPT) Reports Q3 Earnings: What Key Metrics Have to Say Yahoo Finance Tue, 04 Nov 2025 08:00:00 GMT
Sarepta Therapeutics (NASDAQ:SRPT) 
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company offers EXONDYS 51 injection to treat duchenne muscul...
Website: http://www.sarepta.com
Founded: 1980
Full Time Employees: 743
Sector: Healthcare
Industry: Biotechnology